Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2012
02/09/2012WO2012017402A2 Zeolites having a neuro-protective effect
02/09/2012WO2012017385A2 Beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and process for obtaining them
02/09/2012WO2012017383A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, beclomethasone dipropionate, terbinafine hydrochloride and a process to make it
02/09/2012WO2012017382A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, beclomethasone dipropionate, miconazole nitrate and a process make it
02/09/2012WO2012017381A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, beclomethasone dipropionate, clotrimazole and a process to make it
02/09/2012WO2012017372A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, clobetasol propionate, miconazole nitrate and a process to make it
02/09/2012WO2012017371A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clobetasole propionate, terbinafine hydrochloride and a process to make it
02/09/2012WO2012017370A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, betamethasone dipropionate, terbinafine hydrochloride and a process to make it
02/09/2012WO2012017369A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, betamethasone dipropionate, clotrimazole and a process to make it
02/09/2012WO2012017368A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it
02/09/2012WO2012017363A1 Effervescent solid galenic forms for animals
02/09/2012WO2012017349A2 An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine
02/09/2012WO2012017149A1 Device and installation for joining at least two medicine capsules by adhesive bonding
02/09/2012WO2012017077A1 Combination of compounds for treating or preventing skin diseases
02/09/2012WO2012017074A1 Oral pharmaceutical formulations of esomeprazole in the form of mups (multi unit pellets system) tablets
02/09/2012WO2012017022A2 Pharmaceutical composition containing a serenoa repens extract
02/09/2012WO2012016889A2 Dry powder formulation comprising a phosphodiesterase inhibitor
02/09/2012WO2012016845A2 Pharmaceutical formulation comprising a phosphodiesterase inhibitor
02/09/2012WO2012016708A1 Oral dosage form comprising dimebolin and donepezil
02/09/2012WO2012016707A2 Oral dosage form for the modified release of dimebolin
02/09/2012WO2012016703A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012WO2012016699A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012WO2012016698A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
02/09/2012WO2012016697A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
02/09/2012WO2012016695A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012WO2012016691A1 Use of glyceryl trinitrate for treating traumatic edema
02/09/2012WO2012016690A1 Use of glyceryl trinitrate for treating hematomas
02/09/2012WO2012016683A2 Oral dosage form of pregabalin
02/09/2012WO2012016646A1 Quetiapine tablets
02/09/2012WO2011156822A3 Pharmaceutical compositions
02/09/2012WO2011134944A3 Low-oil pharmaceutical emulsion compositions comprising progestogen
02/09/2012WO2011076621A3 Transdermal therapeutic system for administering rivastigmine or derivatives thereof
02/09/2012WO2011062906A8 Treatment of atrial fibrillation
02/09/2012US20120035547 Medication delivery system and monitor
02/09/2012US20120035225 Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
02/09/2012US20120035205 Treatment for basal cell carcinoma
02/09/2012US20120035146 Implants and methods for treating inflammation-mediated conditions of the eye
02/09/2012US20120035121 Antibiotic product, use and formulation thereof
02/09/2012US20120035107 Compositions for achieving a therapeutic effect in an anatomical structure
02/09/2012US20120034462 Hair-like shaped hydrogels for soft tissue augmentation
02/09/2012US20120034307 Aqueous gel formulation and method for inducing topical anesthesia
02/09/2012US20120034306 Polymeric drug delivery systems and processes for producing such systems
02/09/2012US20120034305 Solid dispersing vaccine composition for oral delivery
02/09/2012US20120034304 Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)Phenol
02/09/2012US20120034303 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
02/09/2012US20120034302 Particulate composition and the method of making the same
02/09/2012US20120034301 Tablet and pestle therefor
02/09/2012US20120034300 Stabilized zolpidem pharmaceutical compositions
02/09/2012US20120034299 Compositions for the treatment of gluten intolerance and uses thereof
02/09/2012US20120034298 Chewable Soft Capsule
02/09/2012US20120034297 Pharmaceutical dosage forms comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012US20120034296 Prolonged duration local anesthesia with minimal toxicity
02/09/2012US20120034295 Chimeric small molecules for the recruitment of antibodies to cancer cells
02/09/2012US20120034294 Method of making small liposomes
02/09/2012US20120034293 Transdermal delivery of cannabinoids
02/09/2012US20120034292 Composition For Transdermal Delivery Of Fentanyl
02/09/2012US20120034291 Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications
02/09/2012US20120034279 Transscleral delivery
02/09/2012US20120034278 Ophthalmic preparation containing menthyl ester of indomethacin
02/09/2012US20120034277 Resuscitation fluid
02/09/2012US20120034276 Solid preparation
02/09/2012US20120034275 Powder formulations for inhalation, comprising enantiomerically pure beta agonists
02/09/2012US20120034274 Pharmaceutical composition comprising one or more fumaric acid esters
02/09/2012US20120034273 Extrudate having spicular active substances
02/09/2012US20120034272 Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic
02/09/2012US20120034271 Injectable in-situ crosslinked hydrogel and methods of making and using thereof
02/09/2012US20120034172 Pharmaceutical formulation comprising a phosphodiesterase inhibitor
02/09/2012US20120034169 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
02/09/2012US20120034164 Truncated car peptides and methods and compositions using truncated car peptides
02/09/2012US20120034162 Fullerene Assisted Cell Penetrating Peptides
02/09/2012US20120034157 Artificial cells
02/09/2012US20120034156 Artificial cells
02/09/2012US20120031403 Dry powder formulation comprising a phosphodiesterase inhibitor
02/09/2012DE102010033527A1 Quetiapin-Tabletten Quetiapine tablets
02/09/2012CA2817879A1 Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
02/09/2012CA2810267A1 Combination of compounds for treating or preventing skin diseases
02/09/2012CA2807537A1 Combined drug delivery methods and apparatus
02/09/2012CA2807528A1 St-246 liquid formulations and methods
02/09/2012CA2807508A1 Subconjunctival implant for posterior segment drug delivery
02/09/2012CA2807483A1 Devices, systems, and methods for excavating cancer cells
02/09/2012CA2807406A1 Pharmaceutical formulation comprising a phosphodiesterase inhibitor
02/09/2012CA2807376A1 Collagen-based implants for sustained delivery of drugs
02/09/2012CA2807357A1 Microparticle formulation for pulmonary drug delivery of anti-infective molecule for treatment of infectious diseases
02/09/2012CA2807314A1 Film-forming composition for soft capsules
02/09/2012CA2807274A1 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof
02/09/2012CA2807256A1 Dry powder formulation comprising a phosphodiesterase inhibitor
02/09/2012CA2807225A1 Pharmaceutical preparation for controlling water-soluble drug release
02/09/2012CA2807224A1 Preparation for treatment of spinal cord injury
02/09/2012CA2807150A1 Corticosteroids for the treatment of joint pain
02/09/2012CA2807141A1 Compositions and methods for inducing immune tolerance
02/09/2012CA2807139A1 Liposome targeting compounds and related uses
02/09/2012CA2807033A1 Composition for regeneratng normal tissue from fibrotic tissue
02/09/2012CA2806752A1 Oral dosage form of pregabalin
02/09/2012CA2806636A1 Use of glyceryl trinitrate for treating traumatic edema
02/09/2012CA2806519A1 Beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and process for obtaining them
02/09/2012CA2805999A1 Device and installation for joining at least two medicine capsules by adhesive bonding
02/09/2012CA2805525A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
02/09/2012CA2805523A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
02/09/2012CA2804878A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/2012CA2804077A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
1 ... 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 ... 2991